מאמרים בשיתוף אונקוטסט
מאמרים בשיתוף אונקוטסט
אונקוטסט
>
מאמרים בשיתוף אונקוטסט
>
The impact of the Oncotype DX Recurrence Score on treatment decisions and clinical outcomes in patients with early breast cancer:the Maccabi Healthcare Services experience with a unified testing policy
עדכונים > מאמרים בשיתוף אונקוטסט
17/12/2013
The impact of the Oncotype DX Recurrence Score on treatment decisions and clinical outcomes in patients with early breast cancer:the Maccabi Healthcare Services experience with a unified testing policy
The impact of the Oncotype DX Recurrence Score on treatment decisions and clinical outcomes in patients with early breast cancer:the Maccabi Healthcare Services experience with a unified testing policy
Siegelmann-Danieli et al, 2013 ecancer medical sciences
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3869476/
Authors:
Nava Siegelmann-Danieli, Barbara Silverman, Aviad Zick, Anat Beit-Or, Itzhak Katzir, and Avi Porath